NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

Last Close
May 08 04:00PM ET
8.69
Dollar change
-2.31
Percentage change
-20.95
%
Index- P/E- EPS (ttm)-233.19 Insider Own16.58% Shs Outstand0.67M Perf Week-26.75%
Market Cap5.86M Forward P/E- EPS next Y-5.68 Insider Trans0.00% Shs Float0.56M Perf Month84.22%
Income-38.49M PEG- EPS next Q-10.82 Inst Own1.67% Short Float9.51% Perf Quarter-58.82%
Sales11.69M P/S0.50 EPS this Y81.79% Inst Trans-1.15% Short Ratio0.50 Perf Half Y-66.56%
Book/sh13.79 P/B0.63 EPS next Y76.14% ROA-73.89% Short Interest0.05M Perf Year-98.17%
Cash/sh11.87 P/C0.73 EPS next 5Y- ROE-522.60% 52W Range4.02 - 502.35 Perf YTD-65.56%
Dividend Est.- P/FCF- EPS past 5Y86.61% ROI-113.35% 52W High-98.27% Beta0.94
Dividend TTM- Quick Ratio1.11 Sales past 5Y37.18% Gross Margin63.10% 52W Low116.29% ATR (14)1.60
Dividend Ex-Date- Current Ratio1.63 EPS Y/Y TTM95.65% Oper. Margin-263.76% RSI (14)47.37 Volatility13.94% 20.79%
Employees49 Debt/Eq3.74 Sales Y/Y TTM19.75% Profit Margin-329.30% Recom1.00 Target Price16.00
Option/ShortNo / Yes LT Debt/Eq2.48 EPS Q/Q90.02% Payout- Rel Volume0.75 Prev Close11.00
Sales Surprise12.90% EPS Surprise20.43% Sales Q/Q52.57% EarningsMar 31 BMO Avg Volume105.51K Price8.69
SMA201.34% SMA500.06% SMA200-60.69% Trades Volume81,415 Change-20.95%
Date Action Analyst Rating Change Price Target Change
Jul-07-21Initiated Cantor Fitzgerald Overweight $5
Jul-11-17Initiated Rodman & Renshaw Buy $2
May-08-25 09:30AM
May-07-25 09:15AM
Apr-30-25 08:15AM
Apr-28-25 08:15AM
Apr-17-25 09:00AM
09:50AM Loading…
Apr-16-25 09:50AM
Apr-15-25 09:30AM
Apr-08-25 08:30AM
Apr-04-25 04:15PM
Apr-01-25 04:15PM
Mar-31-25 09:57AM
08:00AM
Mar-28-25 09:00AM
Mar-27-25 08:30AM
Mar-26-25 11:00AM
09:25AM Loading…
09:25AM
07:00AM
Mar-25-25 07:00AM
Mar-18-25 08:30AM
Mar-13-25 04:15PM
Feb-27-25 08:30AM
Feb-19-25 09:00AM
Feb-18-25 09:00AM
07:00AM
Feb-13-25 09:05AM
Feb-06-25 10:00AM
Feb-03-25 09:30AM
Jan-29-25 08:30AM
Jan-22-25 09:00AM
Jan-10-25 04:15PM
08:30AM Loading…
Jan-08-25 08:30AM
08:30AM
Jan-07-25 10:00AM
Dec-19-24 09:00AM
Dec-18-24 10:00AM
Dec-17-24 08:30AM
Dec-16-24 07:00AM
Dec-13-24 10:00AM
Dec-12-24 09:00AM
Dec-09-24 10:00AM
Dec-06-24 08:30AM
Dec-05-24 12:00PM
Dec-04-24 07:00AM
Dec-03-24 07:00AM
Dec-02-24 10:00AM
Nov-25-24 10:00AM
Nov-22-24 08:45AM
Nov-19-24 09:30AM
Nov-14-24 02:08AM
Nov-13-24 08:00AM
Nov-11-24 08:30AM
Nov-06-24 10:00AM
Nov-04-24 08:30AM
Oct-29-24 10:00AM
Oct-16-24 08:30AM
Oct-11-24 04:15PM
Oct-10-24 10:00AM
Oct-09-24 06:16PM
Oct-08-24 08:30AM
Oct-02-24 06:52AM
Oct-01-24 08:30AM
Sep-26-24 10:00AM
Sep-25-24 08:30AM
Sep-24-24 10:00AM
Sep-16-24 10:00AM
Sep-10-24 10:00AM
Sep-06-24 10:00AM
Sep-05-24 08:30AM
Sep-04-24 10:00AM
Aug-27-24 10:00AM
Aug-20-24 10:00AM
Aug-19-24 10:00AM
Aug-13-24 08:00AM
Aug-12-24 10:00AM
Aug-05-24 10:18AM
Aug-02-24 10:00AM
Aug-01-24 09:00AM
Jul-31-24 10:00AM
Jul-23-24 12:13PM
08:00AM
Jul-18-24 10:30AM
Jun-26-24 08:30AM
Jun-21-24 04:15PM
Jun-12-24 08:30AM
Jun-07-24 04:15PM
May-29-24 08:30AM
May-28-24 08:30AM
May-23-24 08:30AM
May-20-24 10:25AM
09:37AM
07:36AM
May-17-24 04:49PM
04:15PM
May-15-24 03:02AM
May-14-24 10:52AM
08:00AM
May-13-24 12:35PM
May-09-24 10:35AM
May-08-24 08:30AM
May-07-24 12:31PM
Jaguar Health, Inc. is a commercial stage pharmaceuticals company, which engages in the development of gastrointestinal products. It operates through the Human Health and Animal Health segments. The Human Health segment is involved in manufacturing human products and the ongoing advertising of Mytesi, which is used for the symptomatic relief of non-infectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. The Animal Health segment includes commercializing prescription and non-prescription products for companion and production animals. The company was founded by Lisa A. Conte on June 6, 2013 and is headquartered in San Francisco, CA.